Vireo AS is raising non-recourse debt to construct a bio-LNG plant in Norway, positioning itself to become a leading bioenergy producer.
Target Information
Vireo AS, founded in 2021, specializes in the development, construction, and operation of bio-LNG production plants. The company aims to establish itself as the leading bio-LNG producer in Norway. It is currently engaged in raising non-recourse debt for its second greenfield bio-LNG facility, the Lista Biogas plant, located on the southern coast of Norway. This plant will process approximately 160,000 tons of feedstock annually, which includes manure, fish, and food waste, with an expected annual production of around 90 GWh of liquefied biomethane.
Industry Overview in Norway
The bioenergy sector in Norway has seen significant growth due to an increasing demand for renewable energy sources and environmental sustainability. The country's focus on reducing greenhouse gas emissions has encouraged investments in bioenergy technologies, including bio-LNG production. This shift is further supported by legislative measures and government initiatives aimed at promoting cleaner energy alternatives.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Norway is rich in natural resources and has abundant feedstocks available for bioenergy production, making it an attractive location for bio-LNG facilities.
Similar Deals
ORLEN Upstream Norway → Albuskjell and Vest Ekofisk
2025
Equinor, Vår Energi, Petoro → Isflak discovery
2025
Vireo AS
invested in
Lista Biogas plant
in 2025
in a Other deal